| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fluorouracil | FAERS: 2 | US FAERS | |
| 2 | Ibuprofen | FAERS: 2 | US FAERS | |
| 3 | Rivaroxaban | FAERS: 2 | US FAERS | |
| 4 | Dabigatran | FAERS: 1 | US FAERS | |
| 5 | Ticagrelor | FAERS: 1 | US FAERS | |
| 6 | Tinzaparin | FAERS: 1 | US FAERS | |
| 7 | Valsartan | FAERS: 1 | US FAERS | |
| 8 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 9 | Octreotide | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Vancomycin | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.